| 86.56 Delayed Data As of Sep 20 |  +0.46 / +0.53%Today’s Change | 71.83 Today|||52-Week Range 103.00 | +10.20% Year-to-Date |
| Previous close | 86.10 |
| Today’s open | 86.33 |
| Day’s range | 86.23 - 87.63 |
| Volume | 707,694 |
| Average volume (3 months) | 787,315 |
| Market cap | $9.6B |
| Earnings growth (last year) | +51.98% |
| Earnings growth (this year) | +11.88% |
| Earnings growth (next 5 years) | +16.78% |
| Revenue growth (last year) | +23.08% |
| P/E ratio | 38.3 |
| Price/Sales | 3.10 |
| Price/Book | 3.71 |
| Today’s change | Today’s % change | |
|---|---|---|
| BIOBio Rad Laboratories... | +5.51 | +1.62% |
| QGENQiagen NV | -0.15 | -0.44% |
| BRKRBruker Corp | +0.01 | +0.02% |
| WATWaters Corp | 0.00 | 0.00% |
| Next reporting date | October 31, 2019 |
| EPS forecast (this quarter) | $1.01 |
| Annual revenue (last year) | $2.8B |
| Annual profit (last year) | $238.8M |
| Net profit margin | 8.55% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Robert F. Friel |
President, Chief Operating Officer & Director Prahlad Ramadhar Singh |
Corporate headquarters Waltham, Massachusetts |
